The rule of three in AML induction—is cladribine the answer?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2012.98.pdf
Reference10 articles.
1. Appelbaum, F. R. in Clinical Oncology 4th edn Ch. 104 (eds Abeloff, M. D. et al.) 2215–2234 (Elsevier, Philadelphia, USA, 2008).
2. Burnett, A. K. et al. Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial. J. Clin. Oncol. 29, 369–377 (2011).
3. Holowiecki, J. et al. Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2011.37.1286 .
4. Holowiecki, J. et al. Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. Leukemia 18, 989–997 (2004).
5. Fernandez, H. F. et al. Anthracycline dose intensification in acute myeloid leukemia. N. Engl. J. Med. 361, 1249–1259 (2009).
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cladribine in the remission induction of adult acute myeloid leukemia: where do we stand?;Annals of Hematology;2018-11-23
2. Minimal Residual Disease in Acute Myeloid Leukemia;Advances in Experimental Medicine and Biology;2018
3. Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy;Annals of Pharmacotherapy;2017-12-14
4. Emerging cell cycle inhibitors for acute myeloid leukemia;Expert Opinion on Emerging Drugs;2017-04-03
5. What Is the Optimal Induction Therapy for Younger Fit Patients With AML?;Current Hematologic Malignancy Reports;2016-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3